If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
GASTROENTEROLOGY
Tillotts supplement • emjreviews.com
INSIDE
How to Improve Your Success
in Treating Mild and Moderate
Inflammatory Bowel Disease
HOW TO IMPROVE YOUR SUCCESS IN TREATING MILD
AND MODERATE INFLAMMATORY BOWEL DISEASE
Summary of presentations from the Tillotts Pharma-sponsored
Satellite Symposium on Inflammatory Bowel Disease, held in
Amsterdam, Netherlands, on 18th March 2016
Chairperson
Geert D’Haens1
Speakers
Ailsa Hart,2 Pieter Hindryckx3
1. Academic Medical Centre-IBD Unit, University of Amsterdam, Amsterdam, Netherlands
2. Director, IBD Unit, St Mark’s Hospital, London, UK
3. Research Gastroenterologist, Department of Gastroenterology,
University Hospital of Ghent, Ghent, Belgium
Disclosure: Within the last 3 yea
GASTROENTEROLOGY Tillotts supplement • emjreviews
HOW TO IMPROVE YOUR SUCCESS IN TREATING MILD AN
Success Factors in the Treatment of Mild-to-Moder
escalating treatment.8 For patients with refracto
Predictors of non-adherence in chronic disea
including an American cohort study (N=248).2
on azathioprine as a maintenance therapy. In 2002
Educational interventions to improve patients
of inflammatory bowel diseases: new insights